Mutual fund · Aggressive Hybrid
HDFC Aggressive Hybrid Fund
₹21,158 cr across 58 positions, as filed for 2026-09-30. Returns are the fund's AMFI growth-plan NAV; holdings and behavior come from its filed monthly portfolios.
Returns, against the category
Q2 FY27: −6% over 1 year against the median Aggressive Hybrid fund's −1%.
| Over | Quarter | 1 year | 3 years (ann.) | 5 years (ann.) |
|---|---|---|---|---|
| HDFC Aggressive Hybrid Fund | −3% | −6% | +5% | +7% |
| Median Aggressive Hybrid fund | −2% | −1% | +9% | +8% |
+18%Q3 FY24+23%Q4 FY24+22%Q1 FY25+24%Q2 FY25+13%Q3 FY25+7%Q4 FY25+7%Q1 FY260%Q2 FY26+6%Q3 FY26−5%Q4 FY26−6%Q1 FY27−6%Q2 FY27
What moved the fund, last 12 filed months
Contribution = the fund's filed weight each month × that stock's price move in its own filings, in percentage points of NAV. Corporate-action months are left out.
| Stock | 12 months | Latest month |
|---|---|---|
| State Bank of India | +1.0 pp | −0.3 pp |
| Divis Laboratories Ltd. | +0.6 pp | −0.0 pp |
| Redington Ltd. | +0.5 pp | +0.1 pp |
| Kotak Mahindra Bank Limited | +0.4 pp | −0.0 pp |
| Axis Bank Ltd. | +0.4 pp | −0.2 pp |
| Stock | 12 months | Latest month |
|---|---|---|
| HDFC Bank Ltd. | −1.9 pp | −0.0 pp |
| Infosys Limited | −1.0 pp | −0.3 pp |
| ITC LIMITED | −0.9 pp | +0.0 pp |
| Zensar Technologies Ltd. | −0.8 pp | −0.1 pp |
| Eris Lifesciences Ltd | −0.6 pp | −0.1 pp |
Holdings, as filed for 2026-09-30
| Holding | Sector | % of fund | Value | Held for | Vs avg cost |
|---|---|---|---|---|---|
| HDFC Bank | Financial Services | 7.01% | ₹1,483 cr | 46 mo | -12% |
| ICICI Bank | Financial Services | 6.87% | ₹1,454 cr | 46 mo | +48% |
| Reliance Industries Limited | Oil, Gas & Consumable Fuels | 4.15% | ₹878 cr | 46 mo | -7% |
| Kotak Mahindra Bank Limited | Financial Services | 3.45% | ₹730 cr | 41 mo | +15% |
| Axis Bank | Financial Services | 3.19% | ₹674 cr | 46 mo | +28% |
| State Bank of India | Financial Services | 2.86% | ₹604 cr | 46 mo | +56% |
| Larsen & Toubro Limited | Construction | 2.14% | ₹454 cr | 46 mo | +79% |
| Divi's Laboratories Limited | Healthcare | 2.09% | ₹442 cr | 12 mo | +44% |
| Maruti Suzuki India Limited | Automobile and Auto Components | 2.03% | ₹429 cr | 15 mo | -10% |
| Bharti Airtel Limited | Telecommunication | 1.99% | ₹422 cr | 46 mo | +118% |
| Infosys | Information Technology | 1.88% | ₹398 cr | 46 mo | -34% |
| Eternal Ltd | Consumer Services | 1.77% | ₹375 cr | 21 mo | +35% |
| Krishna Institute of Medical Sciences Limited | Healthcare | 1.48% | ₹313 cr | 35 mo | +89% |
| InterGlobe Aviation Limited | Services | 1.41% | ₹299 cr | 7 mo | +24% |
| Eris Lifesciences Limited | Healthcare | 1.39% | ₹293 cr | 34 mo | +26% |
How this fund actually behaves
Computed from every filed monthly portfolio (46 months of filings) by the research pipeline.
| Holding patience | Median months a position is held (25th–75th band) | 13 mo (4–19) |
| Win rate on exits | Closed positions sold above entry, and the payoff ratio (22 exits) | 68% · payoff 3.8× |
| Loser handling | Cuts losers vs averages down, from 12 months of filings | Mixed |
| Entry valuation discipline | Median P/E paid on entries over 36 months; share above 50× | 35× · 34% over 50× |
| Portfolio valuation today | Weighted P/E and P/B of the current book at filed prices | 32.6× P/E · 5.4× P/B · 2% loss-makers |
| Churn | Stocks entered and exited in 12 months, of 58 positions | 20 in · 3 out |
| Concentration | Top 10 holdings' share; effective number of positions | 36% · ~26 effective |